| Clarithromycin Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Clarithromycin 500 mg | tablet | oral | 1.0 each | OTC |
| Clarithromycin 250 mg | tablet | oral | 1.0 each | OTC |
| Clarithromycin 250 mg/5 mL | powder for reconstitution | oral | 5.0 milliliter(s) | OTC |
| Clarithromycin 125 mg/5 mL | powder for reconstitution | oral | 5.0 milliliter(s) | OTC |
| Clarithromycin 500 mg | tablet, extended release | oral | 1.0 each | OTC |
Posted by seafoam about 1 month ago
white tongue, severe nausea, and stomach pains. but i'm taking it with amoxicillin too, (for doudenal ulcer treatment) so it ...
Posted by mind over 2 years ago
headech
hypertension
orang color of urine
nausea
vomiting
upper GI bleeding
asthma
palpitations
heamylsis
neutrope...
Posted by clmoon over 3 years ago
I am not sure if i am having a reaction to this medication. at the beginning of december i was given cefzil for a sinus infec...
Esomeprazole. esomeprazole - Cheap Prices. - Fatman Games
In both esomeprazole and, clarithromycin. To maintain healing the patient developed for patients taking NEXIUM compared to short-term treatment. ...
Sat Mar 01 20:13:41 -0500 2008
H. Pylori Agent - How it Works - Best Syndication
Used in combination with clarithromycin to treat active duodenal ulcers caused by H. pylori infection. Do not use ranitidine bismuth citrate alone. ...
Tue Feb 19 14:09:46 -0500 2008
Abbott Reports 16.1 Percent Sales Growth in Fourth Quarter - MSN Money
... Kaletra sales increased 27.1 percent internationally. c Without the positive impact of exchange of 8.1 percent, clarithromycin sales decreased 5.8 ...
Wed Jan 23 07:46:51 -0500 2008
clarithromycin - A semisynthetic 14-membered ring macrolide antibiotic. Clarithromycin binds to the 50S ribosomal subunit and inhibits RNA-dependent protein synthesis in susceptible organisms. Clarithromycin has been shown to eradicate gastric MALT (mucosa-associated lymphoid tissue) lymphomas, presumably due to the eradication of tumorigenic Helicobacter pylori infection. This agent also acts as a biological response modulator, possibly inhibiting angiogenesis and tumor growth through alterations in growth factor expression. (NCI04)